APA (7th ed.) Citation

Li, F., Hu, Z., Huang, Y., & Zhan, H. (2023). Dexmedetomidine ameliorates diabetic cardiomyopathy by inhibiting ferroptosis through the Nrf2/GPX4 pathway. Journal of cardiothoracic surgery, 18(1), 223-8. https://doi.org/10.1186/s13019-023-02300-7

Chicago Style (17th ed.) Citation

Li, Fan, Zhenfei Hu, Yidan Huang, and Haiting Zhan. "Dexmedetomidine Ameliorates Diabetic Cardiomyopathy by Inhibiting Ferroptosis Through the Nrf2/GPX4 Pathway." Journal of Cardiothoracic Surgery 18, no. 1 (2023): 223-8. https://doi.org/10.1186/s13019-023-02300-7.

MLA (9th ed.) Citation

Li, Fan, et al. "Dexmedetomidine Ameliorates Diabetic Cardiomyopathy by Inhibiting Ferroptosis Through the Nrf2/GPX4 Pathway." Journal of Cardiothoracic Surgery, vol. 18, no. 1, 2023, pp. 223-8, https://doi.org/10.1186/s13019-023-02300-7.